Insiders · CINC

CINC insider transactions

CinCor Pharma Inc. (CINC) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for CINC

• 1195d
  SEC Form 4 filed by 5am Partners Vi, Llc

  4 - CinCor Pharma, Inc. (0001868734) (Issuer)
• 1196d
  SEC Form 4: Healy James returned 19,608 shares to the company and sold $85,920 worth of shares (6,000 units at $14.32), closing all direct ownership in the company

  4 - CinCor Pharma, Inc. (0001868734) (Issuer)
• 1196d
  SEC Form 4: Freeman Mason returned 40,000 shares to the company and sold $91 worth of shares (6 units at $15.21), closing all direct ownership in the company to satisfy withholding tax

  4 - CinCor Pharma, Inc. (0001868734) (Issuer)
• 1199d
  SEC Form 4 filed by Allison David D.

  4 - CinCor Pharma, Inc. (0001868734) (Issuer)
• 1199d
  SEC Form 4 filed by Ignelzi Troy A.

  4 - CinCor Pharma, Inc. (0001868734) (Issuer)
• 1199d
  SEC Form 4: Kalb Michael Wayne returned 202,437 shares to the company, closing all direct ownership in the company

  4 - CinCor Pharma, Inc. (0001868734) (Issuer)
• 1199d
  SEC Form 4 filed by Lee June

  4 - CinCor Pharma, Inc. (0001868734) (Issuer)
• 1199d
  SEC Form 4: Pearce Catherine returned 15,000 shares to the company, closing all direct ownership in the company (tax withholding)

  4 - CinCor Pharma, Inc. (0001868734) (Issuer)
• 1199d
  SEC Form 4 filed by Thero John F

  4 - CinCor Pharma, Inc. (0001868734) (Issuer)
• 1199d
  SEC Form 4: De Garidel Marc returned 200,000 shares to the company, closing all direct ownership in the company to cover taxes

  4 - CinCor Pharma, Inc. (0001868734) (Issuer)
• 1224d
  SEC Form 4: De Garidel Marc was granted 200,000 shares, increasing direct ownership by 1,600% to 212,500 units

  4 - CinCor Pharma, Inc. (0001868734) (Issuer)
• 1224d
  SEC Form 4: Pearce Catherine was granted 15,000 shares, increasing direct ownership by 11% to 155,149 units

  4 - CinCor Pharma, Inc. (0001868734) (Issuer)
• 1224d
  SEC Form 4: Kalb Michael Wayne was granted 177,000 shares, increasing direct ownership by 696% to 202,437 units

  4 - CinCor Pharma, Inc. (0001868734) (Issuer)
• 1224d
  SEC Form 4: Freeman Mason was granted 40,000 shares, increasing direct ownership by 1,600% to 42,500 units

  4 - CinCor Pharma, Inc. (0001868734) (Issuer)
• 1235d
  SEC Form 4: Pearce Catherine converted options into 13,235 shares and covered exercise/tax liability with 3,997 shares, increasing direct ownership by 7% to 140,149 units

  4 - CinCor Pharma, Inc. (0001868734) (Issuer)
• 1244d
  SEC Form 4 filed by Allison David D.

  4 - CinCor Pharma, Inc. (0001868734) (Issuer)
• 1307d
  SEC Form 4: Kalb Michael Wayne was granted 25,437 shares

  4 - CinCor Pharma, Inc. (0001868734) (Issuer)
• 1307d
  SEC Form 3 filed by new insider Kalb Michael Wayne

  3 - CinCor Pharma, Inc. (0001868734) (Issuer)
• 1334d
  SEC Form 4 filed by Allison David D.

  4 - CinCor Pharma, Inc. (0001868734) (Issuer)
• 1390d
  SEC Form 4: 5am Partners Vi, Llc bought $18,000,000 worth of shares (600,000 units at $30.00)

  4 - CinCor Pharma, Inc. (0001868734) (Issuer)
• 1390d
  SEC Form 4: Sofinnova Partners Sas bought $3,999,990 worth of shares (133,333 units at $30.00)

  4 - CinCor Pharma, Inc. (0001868734) (Issuer)
• 1392d
  SEC Form 4: Sofinnova Venture Partners X, L.P. bought $15,000,000 worth of shares (500,000 units at $30.00)

  4 - CinCor Pharma, Inc. (0001868734) (Issuer)
• 1392d
  SEC Form 4: Healy James bought $15,180,000 worth of shares (506,000 units at $30.00)

  4 - CinCor Pharma, Inc. (0001868734) (Issuer)
• 1392d
  SEC Form 4: General Atlantic, L.P. bought $2,490,000 worth of shares (83,000 units at $30.00)

  4 - CinCor Pharma, Inc. (0001868734) (Issuer)
• 1392d
  SEC Form 4: General Atlantic Genpar (Bermuda), L.P. bought $2,490,000 worth of shares (83,000 units at $30.00)

  4 - CinCor Pharma, Inc. (0001868734) (Issuer)
• 1399d
  SEC Form 4: Healy James exercised 29,411 shares at a strike of $13.60

  4 - CinCor Pharma, Inc. (0001868734) (Issuer)
• 1418d
  SEC Form 4 filed by Allison David D.

  4 - CinCor Pharma, Inc. (0001868734) (Issuer)
• 1418d
  SEC Form 4 filed by Allison David D. (Amendment)

  4/A - CinCor Pharma, Inc. (0001868734) (Issuer)
• 1488d
  SEC Form 4 filed by Allison David D.

  4 - CinCor Pharma, Inc. (0001868734) (Issuer)